welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Microlin Bio to Acquire Nucleic Acid Therapeutic Assets of Marina Biotech
Microlin Bio, Inc., a development stage biotechnology company focused on the development of microRNA based therapeutics for cancer, and Marina Biotech, Inc., a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced that the companies have executed a term sheet under which Microlin intends to acquire Marina’s nucleic acid therapeutics assets.
expertly curated content related to this topic
-
Banner MD Anderson Cancer CenterAt Banner MD Anderson Cancer Center, col...
-
Uri Ladabaum, MDUri Ladabaum, MD is a Professor of Medic...
-
Emre I. Gorgun, MDDr. Gorgun obtained his Medical degree f...
-
Sue Clark, MDSue Clark trained in medicine at Cambrid...
-
Dawn Banasiak, MSDawn Banasiak joined Kaiser Permanente i...
-
emmanouil saloustrosHereditary cancer clinic at University h...
-
Nicholas O. Davidson, MDProfessor, Medicine, Director, Departmen...